Insulet
Presence
Insulet is one of the...
Insulet is a company listed under the stock ticker PODD (US).
Executives
View the org chart displaying its 31 main executives
Most searched biographies at Insulet
- Jim Hollingshead, President and Chief Executive Officer
- Timothy Scannell, Chairman of the Board
- Jessica Hopfield, Lead Independent Director
Popular executive movements at Insulet
- Ana Maria Chadwick will join the company as Executive Vice President, Chief Financial Officer and Treasurer on Apr. 22, 2024 (posted on March 21 2024).
- Timothy Stonesifer has joined the company as Director (posted on January 19 2024).
- Flavia Pease has joined the company as Director (posted on January 19 2024).
Click here to view some more movements at Insulet
Create your alert
to follow the executive moves at Insulet.
Medical Equipment
Insulet has 985 competitors including Philips (Netherlands), Medtronic (Ireland) and Thermo Fisher Scientific (United States (USA)).
Popular M&A news in Medical Equipment
- Medigus will change its company name to Xylo Technologies on Apr 12, 2024. (posted on April 12 2024).
- Johnson & Johnson has announced the acquisition of Shockwave Medical (posted on April 6 2024).
- Carlsmed has just announced a $52 Million fundraising (posted on March 22 2024).
Popular contacts in Medical Equipment
News
Press releases by Insulet
- Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024
- Insulet’s Randomized Controlled Trial (OP5-003) Demonstrates Omnipod® 5 Automated Insulin Delivery System is Superior to Pump Therapy
- Insulet Appoints Ana Maria Chadwick as Chief Financial Officer
- Insulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
- Insulet Reports Full Year 2023 Revenue Increase of 30% (30% Constant Currency1) and Fourth Quarter 2023 Revenue Increase of 38% Year-Over-Year (37% Constant Currency)
- Insulet to Present at The Raymond James & Associates 45th Annual Institutional Investors Conference
- Insulet Announces CE Mark Approval of Omnipod® 5 Integration with Abbott FreeStyle Libre 2 Plus Sensor
- Insulet Corporation - Insulet Announces Changes to Board of Directors with Retirements and New Appointments Cookies ButtonBack ButtonSearch IconFilter Icon
- Insulet Corporation - Insulet to Announce Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024 Cookies ButtonBack ButtonSearch IconFilter Icon
- Insulet Corporation - Insulet to Present at Upcoming Investor Conferences Cookies ButtonBack ButtonSearch IconFilter Icon
- View more press releases Close
Social media about Insulet
- Insulet on Wikipedia, Google News & Yahoo Finance
- Insulet on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Jim Hollingshead 
